News by Tag: Lexicon

Lexicon's anti-diabetic drug positively clears phase IIb trials
June 27, 2012
As per the phase IIb clinical trial study of Lexicon's dual inhibitor drug, LX4211 for type 2 resistant diabetes treatment has been shown that the drug shows promising potential in curing the diabetes, along with well tolerated & safety profile

PR HWY Homepage
Submit Press Release
PR Firms Directory
Pricing & Features

prHWY offers affordable press release packages with several enhanced options to maximize exposure. By offering homepage featured press releases at an affordable price, you can take advantage of allowing your news article top placement and visibility. Distribute your business news today with prHWY, the most cost effective press release submission service on the internet!